サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434677

動物用抗菌ペプチド市場：ペプチドタイプ別、製品起源別-2024-2030年の世界予測

Animal Antibacterial Peptide Market by Peptide Type (Anionic Peptides, Cationic Peptides, Linear Cationic Alpha-Helical Peptides), Product Origin (Cattle, Goat, Horse) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
動物用抗菌ペプチド市場：ペプチドタイプ別、製品起源別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用抗菌ペプチド市場規模は2023年に34億8,000万米ドルと推計され、2024年には40億6,000万米ドルに達し、CAGR 16.92%で2030年には104億米ドルに達すると予測されます。

動物用抗菌ペプチドの世界市場

主な市場の統計
基準年[2023］ 34億8,000万米ドル
予測年[2024］ 40億6,000万米ドル
予測年 [2030] 104億米ドル
CAGR（%） 16.92%
動物用抗菌ペプチド Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは動物用抗菌ペプチド市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、動物用抗菌ペプチド市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-動物用抗菌ペプチド市場の市場規模および予測は？

2-動物用抗菌ペプチド市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-動物用抗菌ペプチド市場における技術動向と規制の枠組みは？

4-動物用抗菌ペプチド市場における主要ベンダーの市場シェアは？

5-動物用抗菌ペプチド市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 動物飼料中の成長促進剤として低レベルの抗生物質の使用が増加
      • 人間や動物の感染症を治療するための抗生物質の大量使用
      • 感染症の発生頻度の増加と、効果的で安全な医薬品への需要の高まり
    • 抑制要因
      • 毒性や免疫原性などの臨床応用における懸念
    • 機会
      • 動物のヘルスケアと新製品開発への支出の急増
      • 抗菌ペプチドを組み込んだ薬物療法や治療法に対する意識の高まり
    • 課題
      • 抗生物質耐性の発生率の増加
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 動物用抗菌ペプチド市場ペプチドの種類別

  • アニオン性ペプチド
  • カチオン性ペプチド
  • 直鎖状カチオン性A-ヘリックスペプチド

第7章 動物用抗菌ペプチド市場製品の産地別

  • 牛
  • ヤギ
  • 馬
  • 豚
  • 家禽
  • 羊

第8章 南北アメリカの動物用抗菌ペプチド市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の動物用抗菌ペプチド市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの動物用抗菌ペプチド市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Amicoat
    • Bayer AG
    • Boehringer Ingelheim GmbH
    • CPC Scientific Inc.
    • Dechra Pharmaceuticals PLC
    • Eli Lilly and Company
    • Endovac Animal Health LLC
    • Fort Dodge Animal Health
    • JPT Peptide Technologies
    • Merck & Co. Inc.
    • Mileutis LTD
    • Sanofi-Aventis Groupe S.A.
    • Vetoquinol SA
    • Virbac S.A.
    • Zoetis Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANIMAL ANTIBACTERIAL PEPTIDE MARKET DYNAMICS
  • FIGURE 7. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2023 VS 2030 (%)
  • FIGURE 10. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIONIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CATIONIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LINEAR CATIONIC A-HELICAL PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 10. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY HORSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 102. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 103. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. ANIMAL ANTIBACTERIAL PEPTIDE MARKET LICENSE & PRICING
目次
Product Code: MRR-4369010662D5

[195 Pages Report] The Animal Antibacterial Peptide Market size was estimated at USD 3.48 billion in 2023 and expected to reach USD 4.06 billion in 2024, at a CAGR 16.92% to reach USD 10.40 billion by 2030.

Global Animal Antibacterial Peptide Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.48 billion
Estimated Year [2024] USD 4.06 billion
Forecast Year [2030] USD 10.40 billion
CAGR (%) 16.92%
Animal Antibacterial Peptide Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Animal Antibacterial Peptide Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Antibacterial Peptide Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibacterial Peptide Market, highlighting leading vendors and their innovative profiles. These include Amicoat, Bayer AG, Boehringer Ingelheim GmbH, CPC Scientific Inc., Dechra Pharmaceuticals PLC, Eli Lilly and Company, Endovac Animal Health LLC, Fort Dodge Animal Health, JPT Peptide Technologies, Merck & Co. Inc., Mileutis LTD, Sanofi-Aventis Groupe S.A., Vetoquinol SA, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibacterial Peptide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Peptide Type
    • Anionic Peptides
    • Cationic Peptides
    • Linear Cationic A-Helical Peptides
  • Product Origin
    • Cattle
    • Goat
    • Horse
    • Pig
    • Poultry
    • Sheep
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Animal Antibacterial Peptide Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Antibacterial Peptide Market?

3. What are the technology trends and regulatory frameworks in the Animal Antibacterial Peptide Market?

4. What is the market share of the leading vendors in the Animal Antibacterial Peptide Market?

5. Which modes and strategic moves are suitable for entering the Animal Antibacterial Peptide Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Animal Antibacterial Peptide Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of low levels of antibiotics as growth promoters in animal feeds
      • 5.1.1.2. Extensive use of antibiotics to treat human or animal infections
      • 5.1.1.3. Rising frequency of infectious diseases and the rising demand for effective and safe medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns in clinical applications such as the toxicity, and immunogenicity
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid rise in expenditure on animal healthcare and new product development efforts
      • 5.1.3.2. Growing awareness to medications and therapies incorporating antimicrobial peptides
    • 5.1.4. Challenges
      • 5.1.4.1. Proliferating incidences of antibiotic resistance
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Animal Antibacterial Peptide Market, by Peptide Type

  • 6.1. Introduction
  • 6.2. Anionic Peptides
  • 6.3. Cationic Peptides
  • 6.4. Linear Cationic A-Helical Peptides

7. Animal Antibacterial Peptide Market, by Product Origin

  • 7.1. Introduction
  • 7.2. Cattle
  • 7.3. Goat
  • 7.4. Horse
  • 7.5. Pig
  • 7.6. Poultry
  • 7.7. Sheep

8. Americas Animal Antibacterial Peptide Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Animal Antibacterial Peptide Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Animal Antibacterial Peptide Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Amicoat
    • 12.1.2. Bayer AG
    • 12.1.3. Boehringer Ingelheim GmbH
    • 12.1.4. CPC Scientific Inc.
    • 12.1.5. Dechra Pharmaceuticals PLC
    • 12.1.6. Eli Lilly and Company
    • 12.1.7. Endovac Animal Health LLC
    • 12.1.8. Fort Dodge Animal Health
    • 12.1.9. JPT Peptide Technologies
    • 12.1.10. Merck & Co. Inc.
    • 12.1.11. Mileutis LTD
    • 12.1.12. Sanofi-Aventis Groupe S.A.
    • 12.1.13. Vetoquinol SA
    • 12.1.14. Virbac S.A.
    • 12.1.15. Zoetis Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing